US Stock MarketDetailed Quotes

RGBP REGEN BIOPHARMA INC

Watchlist

0.235
-0.031-11.75%

15min DelayClose Sep 6 16:00 ET

1.06MMarket Cap-940P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

Total revenue

0.00%59.07K

0.44%236.56K

0.00%59.37K

0.59%59.07K

1.19%59.07K

0.00%59.07K

37.57%235.52K

-0.58%59.37K

Operating revenue

0.00%59.07K

0.44%236.56K

0.00%59.37K

0.59%59.07K

1.19%59.07K

0.00%59.07K

37.57%235.52K

-0.58%59.37K

Cost of revenue

Gross profit

Operating expense

15.82%167.03K

16.12%160.14K

-65.23%181.85K

60.58%923.51K

-24.62%118.45K

22.61%144.22K

2.26%137.91K

216.00%522.93K

54.62%575.12K

-15.76%157.15K

Selling and administrative expenses

35.59%134.53K

18.28%120K

-68.57%134.32K

137.28%711.21K

-10.51%83.12K

14.62%99.22K

43.92%101.46K

758.37%427.42K

-10.60%299.73K

-43.96%92.88K

-General and administrative expense

35.59%134.53K

18.28%120K

-68.57%134.32K

137.28%711.21K

-10.51%83.12K

14.62%99.22K

43.92%101.46K

758.37%427.42K

-10.60%299.73K

-43.96%92.88K

Research and development costs

-27.78%32.5K

10.12%40.13K

-50.24%47.53K

-22.91%212.3K

-45.02%35.34K

44.88%45K

-43.38%36.45K

-17.44%95.51K

650.29%275.39K

208.82%64.27K

Operating profit

-26.79%-107.97K

-28.19%-101.07K

73.53%-122.78K

-102.28%-686.95K

39.57%-59.09K

-44.55%-85.16K

-3.07%-78.84K

-335.87%-463.87K

-69.15%-339.61K

22.90%-97.78K

Net non-operating interest income expense

-55.68%-21.89K

-77.10%-21.4K

-27.49%-22.13K

-21.43%-309.45K

-229.83%-265.94K

73.20%-14.06K

81.24%-12.09K

69.72%-17.36K

30.53%-254.83K

33.80%-80.63K

Non-operating interest income

----

--0

----

97.83%455

-58.21%56

Non-operating interest expense

55.68%21.89K

77.10%21.4K

27.49%22.13K

-71.66%59.45K

-54.70%15.94K

-73.27%14.06K

-81.27%12.09K

-69.79%17.36K

-42.84%209.79K

-71.14%35.19K

Total other finance cost

----

449.45%250K

----

--45.5K

----

Other net income (expense)

-261

-109.68%-204.85K

-29.13%2.15M

100.05%35.95K

-24.63%2.12M

149.02%3.04M

108.84%100.38K

Gain on sale of security

---261

----

-109.68%-204.85K

-36.16%2.15M

--0

----

100.05%35.95K

-25.53%2.12M

162.16%3.37M

127.85%100.38K

Special income (charges)

----

--0

101.21%1.15K

--0

----

101.21%1.15K

87.75%-95.02K

--0

-Less:Other special charges

----

-101.21%-1.15K

--0

----

-101.21%-1.15K

-87.75%95.02K

--0

Other non- operating income (expenses)

----

---237.3K

--0

Income before tax

-31.15%-130.12K

-122.77%-122.47K

-121.38%-349.76K

-52.67%1.16M

-316.56%-325.03K

-100.15%-99.22K

99.92%-54.98K

-38.16%1.64M

136.12%2.44M

94.36%-78.03K

Income tax

Net income

-31.15%-130.12K

-122.77%-122.47K

-121.38%-349.76K

-52.67%1.16M

-316.56%-325.03K

-100.15%-99.22K

99.92%-54.98K

-38.16%1.64M

136.12%2.44M

94.36%-78.03K

Net income continuous Operations

-31.15%-130.12K

-122.77%-122.47K

-121.38%-349.76K

-52.67%1.16M

-316.56%-325.03K

-100.15%-99.22K

99.92%-54.98K

-38.16%1.64M

136.12%2.44M

94.36%-78.03K

Minority interest income

Net income attributable to the parent company

-18.03%-117.11K

-122.77%-122.47K

-124.15%-349.76K

-54.04%1.02M

-314.66%-280.24K

-100.16%-99.22K

99.92%-54.98K

-39.42%1.45M

132.92%2.23M

95.12%-67.58K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-18.03%-117.11K

-122.77%-122.47K

-124.15%-349.76K

-54.04%1.02M

-314.66%-280.24K

-100.16%-99.22K

99.92%-54.98K

-39.42%1.45M

132.92%2.23M

95.12%-67.58K

Basic earnings per share

0.00%-0.03

-122.22%-0.1

-59.17%0.29

-920.41%-0.1

-100.16%-0.03

99.86%-0.03

-70.00%0.45

121.04%0.7102

97.39%-0.0098

Diluted earnings per share

0.00%-0.03

-122.22%-0.1

-59.17%0.29

-920.41%-0.1

-100.16%-0.03

99.86%-0.03

-70.00%0.45

121.04%0.7102

97.39%-0.0098

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022
Total revenue	0.00%59.07K	0.00%59.07K	0.00%59.07K	0.44%236.56K	0.00%59.37K	0.59%59.07K	1.19%59.07K	0.00%59.07K	37.57%235.52K	-0.58%59.37K
Operating revenue	0.00%59.07K	0.00%59.07K	0.00%59.07K	0.44%236.56K	0.00%59.37K	0.59%59.07K	1.19%59.07K	0.00%59.07K	37.57%235.52K	-0.58%59.37K
Cost of revenue
Gross profit
Operating expense	15.82%167.03K	16.12%160.14K	-65.23%181.85K	60.58%923.51K	-24.62%118.45K	22.61%144.22K	2.26%137.91K	216.00%522.93K	54.62%575.12K	-15.76%157.15K
Selling and administrative expenses	35.59%134.53K	18.28%120K	-68.57%134.32K	137.28%711.21K	-10.51%83.12K	14.62%99.22K	43.92%101.46K	758.37%427.42K	-10.60%299.73K	-43.96%92.88K
-General and administrative expense	35.59%134.53K	18.28%120K	-68.57%134.32K	137.28%711.21K	-10.51%83.12K	14.62%99.22K	43.92%101.46K	758.37%427.42K	-10.60%299.73K	-43.96%92.88K
Research and development costs	-27.78%32.5K	10.12%40.13K	-50.24%47.53K	-22.91%212.3K	-45.02%35.34K	44.88%45K	-43.38%36.45K	-17.44%95.51K	650.29%275.39K	208.82%64.27K
Operating profit	-26.79%-107.97K	-28.19%-101.07K	73.53%-122.78K	-102.28%-686.95K	39.57%-59.09K	-44.55%-85.16K	-3.07%-78.84K	-335.87%-463.87K	-69.15%-339.61K	22.90%-97.78K
Net non-operating interest income expense	-55.68%-21.89K	-77.10%-21.4K	-27.49%-22.13K	-21.43%-309.45K	-229.83%-265.94K	73.20%-14.06K	81.24%-12.09K	69.72%-17.36K	30.53%-254.83K	33.80%-80.63K
Non-operating interest income	----	----	----	--0	----	----	----	----	97.83%455	-58.21%56
Non-operating interest expense	55.68%21.89K	77.10%21.4K	27.49%22.13K	-71.66%59.45K	-54.70%15.94K	-73.27%14.06K	-81.27%12.09K	-69.79%17.36K	-42.84%209.79K	-71.14%35.19K
Total other finance cost	----	----	----	449.45%250K	----	----	----	----	--45.5K	----
Other net income (expense)	-261		-109.68%-204.85K	-29.13%2.15M	0		100.05%35.95K	-24.63%2.12M	149.02%3.04M	108.84%100.38K
Gain on sale of security	---261	----	-109.68%-204.85K	-36.16%2.15M	--0	----	100.05%35.95K	-25.53%2.12M	162.16%3.37M	127.85%100.38K
Special income (charges)	----	----	--0	101.21%1.15K	--0	----	----	101.21%1.15K	87.75%-95.02K	--0
-Less:Other special charges	----	----	----	-101.21%-1.15K	--0	----	----	-101.21%-1.15K	-87.75%95.02K	--0
Other non- operating income (expenses)	----	----	----	----	----	----	----	----	---237.3K	--0
Income before tax	-31.15%-130.12K	-122.77%-122.47K	-121.38%-349.76K	-52.67%1.16M	-316.56%-325.03K	-100.15%-99.22K	99.92%-54.98K	-38.16%1.64M	136.12%2.44M	94.36%-78.03K
Income tax
Net income	-31.15%-130.12K	-122.77%-122.47K	-121.38%-349.76K	-52.67%1.16M	-316.56%-325.03K	-100.15%-99.22K	99.92%-54.98K	-38.16%1.64M	136.12%2.44M	94.36%-78.03K
Net income continuous Operations	-31.15%-130.12K	-122.77%-122.47K	-121.38%-349.76K	-52.67%1.16M	-316.56%-325.03K	-100.15%-99.22K	99.92%-54.98K	-38.16%1.64M	136.12%2.44M	94.36%-78.03K
Minority interest income
Net income attributable to the parent company	-18.03%-117.11K	-122.77%-122.47K	-124.15%-349.76K	-54.04%1.02M	-314.66%-280.24K	-100.16%-99.22K	99.92%-54.98K	-39.42%1.45M	132.92%2.23M	95.12%-67.58K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-18.03%-117.11K	-122.77%-122.47K	-124.15%-349.76K	-54.04%1.02M	-314.66%-280.24K	-100.16%-99.22K	99.92%-54.98K	-39.42%1.45M	132.92%2.23M	95.12%-67.58K
Basic earnings per share	0.00%-0.03	0.00%-0.03	-122.22%-0.1	-59.17%0.29	-920.41%-0.1	-100.16%-0.03	99.86%-0.03	-70.00%0.45	121.04%0.7102	97.39%-0.0098
Diluted earnings per share	0.00%-0.03	0.00%-0.03	-122.22%-0.1	-59.17%0.29	-920.41%-0.1	-100.16%-0.03	99.86%-0.03	-70.00%0.45	121.04%0.7102	97.39%-0.0098
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall